PROCEEDINGS VOLUME 3563
BIOS EUROPE '98 | 8-12 SEPTEMBER 1998
Photochemotherapy of Cancer and Other Diseases
IN THIS VOLUME

0 Sessions, 20 Papers, 0 Presentations
BIOS EUROPE '98
8-12 September 1998
Stockholm, Sweden
Basic Studies
Proc. SPIE 3563, Mechanism of cell destruction and cell protection during methylene-blue-induced PDT, 0000 (3 February 1999); doi: 10.1117/12.339122
Proc. SPIE 3563, Type III photosensitization: attempt for quantification and a way toward new sensitizers, 0000 (3 February 1999); doi: 10.1117/12.339133
Proc. SPIE 3563, Eradication of bacterial species via photosensitization, 0000 (3 February 1999); doi: 10.1117/12.339135
Proc. SPIE 3563, Characterization of the cellular uptake of 5-aminolevulinic acid, 0000 (3 February 1999); doi: 10.1117/12.339116
Proc. SPIE 3563, Photodynamic treatment of pancreatic cancer cells: genotoxicity and chromosome damage induced by red light and zinc tetrasulfonated phthalocyanines (ZnPcS4), 0000 (3 February 1999); doi: 10.1117/12.339117
Preclinical Studies
Proc. SPIE 3563, Evaluation of photodynamically induced damage to healthy eye tissues of rabbits using the second-generation photosensitizers bacteriochlorin a and mTHPC, 0000 (3 February 1999); doi: 10.1117/12.339118
Proc. SPIE 3563, Chlorins with six-membered imide ring as prospective sensitizers for cancer PDT, 0000 (3 February 1999); doi: 10.1117/12.339119
Proc. SPIE 3563, Experimental study of PDT with aluminum sulphophthalocyanine using sodium ascorbate and hyperbaric oxygenation, 0000 (3 February 1999); doi: 10.1117/12.339120
Proc. SPIE 3563, Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl esther, 0000 (3 February 1999); doi: 10.1117/12.339121
Proc. SPIE 3563, ALA-PDT of the normal rat esophagus: efficiency and safety largely depends on the timing of illumination, 0000 (3 February 1999); doi: 10.1117/12.339123
Photodiagnosis
Proc. SPIE 3563, Latest results of 5-ALA-based fluorescence diagnosis and other medical disciplines, 0000 (3 February 1999); doi: 10.1117/12.339124
Proc. SPIE 3563, Quantitative methods for studying the role of free radicals in biology, 0000 (3 February 1999); doi: 10.1117/12.339125
Proc. SPIE 3563, Effect of wavelength and light dose in photodynamic therapy of the normal rat esophagus with ALA-induced photosensitization, 0000 (3 February 1999); doi: 10.1117/12.339126
Poster Session
Proc. SPIE 3563, Cooperative effects of photosensitized cell killing, 0000 (3 February 1999); doi: 10.1117/12.339127
Proc. SPIE 3563, Theoretical model for fluorescent field calculation in nonhomogeneous and scattering biological tissues, 0000 (3 February 1999); doi: 10.1117/12.339128
Proc. SPIE 3563, Interaction between a photosensitizer, chemotherapeutic drug, and HSA: implications for photodynamic therapy, 0000 (3 February 1999); doi: 10.1117/12.339129
Proc. SPIE 3563, 5-aminolevulinic acid (ALA) mediated photodynamic therapy of bladder cancer cell lines, 0000 (3 February 1999); doi: 10.1117/12.339130
Proc. SPIE 3563, Aluminium sulphophthalocyanine as an NIR photosensitizer for PDT, 0000 (3 February 1999); doi: 10.1117/12.339131
Proc. SPIE 3563, PDT-induced apoptosis in bladder carcinoma cells, 0000 (3 February 1999); doi: 10.1117/12.339132
Proc. SPIE 3563, Clearance of protoporphyrin IX from mouse skin after topical application of 5-aminolevulinic acid and its methyl ester, 0000 (3 February 1999); doi: 10.1117/12.339134
Back to Top